India contributes 22mn USD to global fund for fighting AIDS, TB and Malaria

India shares a sustained partnership with the Global Fund since 2002 both as recipient and as a donor.

Published on: Sep 3, 2019, 21:18:53 IST

Hindustan Times, New Delhi | By Rhythma Kaul

Prefer HTon Google

Share via

Copy link

India has announced its contribution of 22 million US$ to The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFTAM).

Global Fund support with investment of USD 2 billion so far has made significant contribution in attaining targets related to HIV/AIDS, TB and Malaria reduction. (SHUTTERSTOCK.)

The contribution is for the 6th replenishment cycle (2020-22), and an increase of 10% over the amount contributed by the country in the 5th cycle.

“India stands firm to its long-standing partnership with the Global Fund and its commitment to eliminate AIDS, Tuberculosis and Malaria”. India’s pledge for the Global Fund strongly demonstrates its strong political leadership to achieve universal health for all and its equally strong commitment to work across borders to join hands in fighting the epidemics of these three diseases,” said Union health minister Harsh Vardhan, in a statement.

India was the first implementing country to host a replenishment milestone of the Global Fund and now has become the first among G20, BRICS and implementer countries to announce the pledge for the 6th Replenishment Conference, setting a precedent for other donors to contribute generously for the cause.

India shares a sustained partnership with the Global Fund since 2002 both as recipient and as a donor.

Global Fund support with investment of USD 2 billion so far has made significant contribution in attaining targets related to HIV/AIDS, TB and Malaria reduction, and escalating the fight against these three diseases.

In the current funding cycle (2018-21), the Global Fund has allocated US$ 500 million to India. As a donor, India has contributed US$ 46.5 million so far till 2019 including US$ 20 million for the 5th Replenishment.

ABOUT THE AUTHOR
Rhythma Kaul
Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More

Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.